Key facts
- This page summarizes Joel S. Marcus's Form 4 filing for Frequency Therapeutics, Inc. (KRRO).
- 4 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 19 Aug 2022, 16:08.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Disposed to Issuer
Award
Disposed to Issuer
Additional SEC filing notes
Footnote F1
The option vested in full on the earlier of June 11, 2021 or the day immediately prior to the company's 2021 annual meeting of shareholders
Footnote F2
The transaction reported herein reflects a one-time stock option repricing that became effective on August 17, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these options.
Footnote F3
The option vests in full on the earlier of June 11, 2021 or the day immediately prior to the company's 2021 annual meeting of shareholders
Footnote F4
The option vested in full on the earlier of June 17, 2022 or the day immediately prior to the company's 2022 annual meeting of shareholders.
Footnote F5
The option vests in full on the earlier of June 17, 2022 or the day immediately prior to the company's 2022 annual meeting of shareholders.